Search
for
Sort by
Research 751–780 of 1000+
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Thallium poisoning. Diagnosis may be elusive but alopecia is the clue.
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Congenital Adrenal Hyperplasia
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Nutrition and Hair
- Primary cicatricial alopecia
- Nutritional management in women with polycystic ovary syndrome: A review study
- Obesity and polycystic ovary syndrome
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Polycystic Ovarian Syndrome
- Health and fertility in World Health Organization group 2 anovulatory women
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Phospholipase A2 Is Required for PIN-FORMED Protein Trafficking to the Plasma Membrane in the<i>Arabidopsis</i>Root
- Safety of testosterone treatment in postmenopausal women
- Elastic tissue in scars and alopecia
- Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Polycystic Ovary Syndrome: Diagnosis and Treatment